Zdrowie i gospodarka · 30/09/2021

FDA Releases Draft Guidance on Using Electronic Health Records and Medical Claims Data for Regulatory Decision-Making

The FDA is releasing a draft guidance to help industry sponsors and researchers use electronic health records and medical claims data to support regulatory decisions on drug and biological products. The guidance aims to provide considerations for using these data in clinical studies to assess effectiveness or safety.